BRAF Mutation in Colorectal Cancer | IntechOpen
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer | BMC Cancer | Full Text
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer - ScienceDirect
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
Cancers | Free Full-Text | Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Targeting the untargetable KRAS in cancer therapy - ScienceDirect
KRas mutations spectrum in 670 colorectal cancers | Download Table
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
